Research PLD
A 2014 study in the PKD animal model shows Tolvaptan + octreotide to have a synergistic effect on cyst formation, better than either one alone.
V.E. Torres M.D. Medical articles written by Dr. Torres will
reveal most of the major research done today on Polycystic Liver Disease.
If there is a question or if you might need to know your PLD treatment options: a liver resection,
a liver transplant, a TAE, or conservative medical treatment, or nothing at all,
this is the physician to turn to. He has numerous published articles on polycystic organ disease,
particularly PLD Polycystic Liver Disease. One article in the PLD animal model shows a reduction liver cysts from sirolimus.
Listen to the informative PLD lecture below, given June 15, 2004 at a PKD conference. Dr. Vicente Torres has been the past chair of the scientific
advisory committee for PKD Polycystic Kidney Disease. He stepped down as the longest standing member
of the scientific advisory committee. He is Professor of Medicine and Chair of the Division of Nephrology and Hypertension
at the Mayo Clinic Rochester MN USA. The Mayo Clinic Dept of Nephrology was just voted number one
in the nation (USA) for the treatment of kidney disease.
D M Nagorney M.D. Outcomes Durability Hepatic Reduction after
Combined Partial Hepatectomy Cyst Fenestration Massive PLD 2016 his latest paper.
Dr. Nagorney was the first surgeon to suggest a liver resection might be helpful for PLD Polycystic Liver Disease. He is a liver resection surgeon,
devoting himself exclusively to performing liver resections. If one is a candidate for a liver resection, this is the man to perform it. In his surgical
lifetime he has performed perhaps greater than 200 PLD liver resection surgeries.
Peter C. Harris, PhD ADPLD Study. If you have only liver cysts without any kidney cysts, it is likely that you probably have ADPLD,
autosomal dominant polycystic liver disease. For individuals without kidney cysts and only liver cysts, there is an
ongoing genetic study from the Mayo with Dr. Peter Harris, Dr. Torres and together with Yale University.
S. Somlo M.D. ADPLD Genetic Study does gene phenotyping of ADPLD.
This requires a donation of a test tube of your blood. It does not require travel. They
can mail the kit to you and you mail it back in a pre-paid envelope.
J P Drenth M.D. The Netherlands has begun lanreotide clinical trials in Europe. Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.
Marie Hogan M.D. Dr. Hogan is currently heading up clinical trial with
Pasireotide and
chronic long term pain from PKD.
A PLD questionnaire
is also being developed at the Mayo.
Ubara M.D. in Japan has perfected the TAE procedure
for severe PLD polycystic liver disease.Department of Radiology,
Toranomon Hospital Kajigaya, Kawasaki, Kanagawa, Japan.
Tatyana Mas/yuk M.D. The treatment of PLD Polycystic Liver Disease will be explored with the current octreotide study.
Malcolm Ogburn M.D. He no longer works in this area and cannot refer someone to a Canadian doctor.
John F. Valente M.D. Pain Relief - Denervation Laparoscopically for ADPKD
Eiji Higashihara M.D. Water Trial ADPKD
Somatostatin Analogues Octreotide Pasireotide Lanreotide LAR
This is an up and coming medical treatment for PLD. It is still in clinical trials and the side effects and response vary with
each individual, but it is the only new possible medicine available currently for severe PLD.
